1. Home
  2. DTM vs ABVX Comparison

DTM vs ABVX Comparison

Compare DTM & ABVX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo DT Midstream Inc.

DTM

DT Midstream Inc.

HOLD

Current Price

$142.21

Market Cap

12.8B

Sector

Utilities

ML Signal

HOLD

Logo Abivax SA American

ABVX

Abivax SA American

HOLD

Current Price

$116.35

Market Cap

10.5B

Sector

N/A

ML Signal

HOLD

Company Overview

Basic Information
Metric
DTM
ABVX
Founded
2021
2013
Country
United States
France
Employees
N/A
67
Industry
Oil & Gas Production
Sector
Utilities
Exchange
Nasdaq
Nasdaq
Market Cap
12.8B
10.5B
IPO Year
2021
N/A

Fundamental Metrics

Financial Performance
Metric
DTM
ABVX
Price
$142.21
$116.35
Analyst Decision
Buy
Buy
Analyst Count
10
12
Target Price
$134.80
$128.42
AVG Volume (30 Days)
812.0K
724.1K
Earning Date
05-22-2026
01-01-0001
Dividend Yield
2.47%
N/A
EPS Growth
19.44
N/A
EPS
4.30
N/A
Revenue
$1,243,000,000.00
N/A
Revenue This Year
$9.25
N/A
Revenue Next Year
$7.51
$0.22
P/E Ratio
$33.02
N/A
Revenue Growth
26.71
N/A
52 Week Low
$83.30
$4.77
52 Week High
$142.85
$148.83

Technical Indicators

Market Signals
Indicator
DTM
ABVX
Relative Strength Index (RSI) 79.25 45.08
Support Level $102.20 $107.99
Resistance Level N/A $131.27
Average True Range (ATR) 3.65 5.01
MACD 0.44 -1.39
Stochastic Oscillator 95.09 39.63

Price Performance

Historical Comparison
DTM
ABVX

About DTM DT Midstream Inc.

DT Midstream Inc is an owner, operator, and developer of natural gas midstream interstate and intrastate pipelines; storage and gathering systems; and compression, treatment, and surface facilities. It provides multiple, integrated natural gas services to customers through interstate pipelines, intrastate pipelines, storage systems, lateral pipelines and related treatment plants and compression and surface facilities, and gathering systems and related treatment plants and compression and surface facilities. The segments of the group are Pipeline and Gathering. It generates revenue from pipeline, storage, and gathering systems, substantially all of which are located in the Midwestern U.S., Eastern Canada, Northeastern U.S., and Gulf Coast regions.

About ABVX Abivax SA American

Abivax SA is a France-based clinical-stage biotechnology company focused on developing therapeutics that harness the body's natural regulatory mechanisms to stabilize the immune response in patients with chronic inflammatory diseases. Company is evaluating its drug candidate, obefazimod, in Phase 3 clinical trials for the treatment of adults with moderately to severely active ulcerative colitis. Its initial focus is on inflammatory bowel diseases, chronic conditions involving inflammation of the gastrointestinal tract, of which the two common forms are UC and CD.

Share on Social Networks: